Minimal Residual Disease (MRD) follow up of MM patients obtaining stringent complete remission (sCR) in the NMSG/EMN02 clinical trial – defining sCR numbers and prediction of disease progression by multiparametric flow cytometry (MFC).

Hans Erik Johnsen; Alexander Schmitz; Julie Støve Bødker; P. Sonneveld; D. Hofste op Bruinink; B. van der Holt; V. H. J.  van der Velden; N. Abildgaard; L. Ahlberg; N. Andersen; B. Andreasson; L. Brandefors; H. B. Christiansen; S. Faxoe; C. Fransson; M. Friestad; H.  Gregersen; Y. Hammerlund; M. Hansson; E. Haukaas; M.  Hector; C.  Helleberg; M.  Holst; A.K.  Jönsson; V. Karlsson; A.  Klostergaard; S. Kjær; B. Lauri; S. Lenhoff; I. Lonn; E. Myhr; B. H. Pedersen; R. Renna; T. V.  Sjøgren; Asta Svirskaite; D. L. Szatkowski; S. Vangsted; A. Waage; F. H.  Schjesvold; U-H Mellqvist; Helle Høholt; Louise Hvilshøj Madsen; Henning Sand Christensen; Rasmus Froberg Brøndum; Martin Bøgsted; Karen Dybkær

Minimal Residual Disease (MRD) follow up of MM patients obtaining stringent complete remission (sCR) in the NMSG/EMN02 clinical trial – defining sCR numbers and prediction of disease progression by multiparametric flow cytometry (MFC).

Hans Erik Johnsen, Alexander Schmitz, Julie Støve Bødker, P. Sonneveld, D. Hofste op Bruinink, B. van der Holt, V. H. J. van der Velden, N. Abildgaard, L. Ahlberg, N. Andersen, B. Andreasson , L. Brandefors, H. B. Christiansen, S. Faxoe, C. Fransson, M. Friestad, H. Gregersen, Y. Hammerlund, M. Hansson, E. HaukaasM. Hector, C. Helleberg, M. Holst, A.K. Jönsson, V. Karlsson, A. Klostergaard, S. Kjær, B. Lauri, S. Lenhoff, I. Lonn, E. Myhr, B. H. Pedersen, R. Renna, T. V. Sjøgren, Asta Svirskaite, D. L. Szatkowski, S. Vangsted, A. Waage, F. H. Schjesvold, U-H Mellqvist, Helle Høholt, Louise Hvilshøj Madsen, Henning Sand Christensen, Rasmus Froberg Brøndum, Martin Bøgsted, Karen Dybkær

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	BA6
Tidsskrift	Haematologica
Vol/bind	103
Udgave nummer	S1
Sider (fra-til)	13
Antal sider	1
ISSN	0390-6078
Status	Udgivet - 2018
Begivenhed	1st European Myeloma Network Meeting - Lingotto Conference Center, Torino, Italien Varighed: 19 apr. 2018 → 21 apr. 2018 Konferencens nummer: 1 http://www.emn2018.com/

Konference

Konference	1st European Myeloma Network Meeting
Nummer	1
Lokation	Lingotto Conference Center
Land/Område	Italien
By	Torino
Periode	19/04/2018 → 21/04/2018
Internetadresse	http://www.emn2018.com/

Adgang til dokumentet

http://www.emn2018.com/doc/Abstract-book.pdf

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Andre filer og links

Konferencens hjemmeside

Citationsformater

Johnsen, H. E., Schmitz, A., Bødker, J. S., Sonneveld, P., Hofste op Bruinink, D., van der Holt, B., van der Velden, V. H. J., Abildgaard, N., Ahlberg, L., Andersen, N., Andreasson , B., Brandefors, L., Christiansen, H. B., Faxoe, S., Fransson, C., Friestad, M., Gregersen, H., Hammerlund, Y., Hansson, M., ... Dybkær, K. (2018). Minimal Residual Disease (MRD) follow up of MM patients obtaining stringent complete remission (sCR) in the NMSG/EMN02 clinical trial – defining sCR numbers and prediction of disease progression by multiparametric flow cytometry (MFC). Haematologica, 103(S1), 13. Artikel BA6. http://www.emn2018.com/doc/Abstract-book.pdf

@article{2e93ef3ea0c142fd91fc9ee0616eb58b,

title = "Minimal Residual Disease (MRD) follow up of MM patients obtaining stringent complete remission (sCR) in the NMSG/EMN02 clinical trial – defining sCR numbers and prediction of disease progression by multiparametric flow cytometry (MFC).",

author = "Johnsen, {Hans Erik} and Alexander Schmitz and B{\o}dker, {Julie St{\o}ve} and P. Sonneveld and {Hofste op Bruinink}, D. and {van der Holt}, B. and {van der Velden}, {V. H. J.} and N. Abildgaard and L. Ahlberg and N. Andersen and B. Andreasson and L. Brandefors and Christiansen, {H. B.} and S. Faxoe and C. Fransson and M. Friestad and H. Gregersen and Y. Hammerlund and M. Hansson and E. Haukaas and M. Hector and C. Helleberg and M. Holst and A.K. J{\"o}nsson and V. Karlsson and A. Klostergaard and S. Kj{\ae}r and B. Lauri and S. Lenhoff and I. Lonn and E. Myhr and Pedersen, {B. H.} and R. Renna and Sj{\o}gren, {T. V.} and Asta Svirskaite and Szatkowski, {D. L.} and S. Vangsted and A. Waage and Schjesvold, {F. H.} and U-H Mellqvist and Helle H{\o}holt and Madsen, {Louise Hvilsh{\o}j} and Christensen, {Henning Sand} and Br{\o}ndum, {Rasmus Froberg} and Martin B{\o}gsted and Karen Dybk{\ae}r",

year = "2018",

language = "English",

volume = "103",

pages = "13",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "S1",

note = "1st European Myeloma Network Meeting ; Conference date: 19-04-2018 Through 21-04-2018",

url = "http://www.emn2018.com/",

}

Johnsen, HE, Schmitz, A, Bødker, JS, Sonneveld, P, Hofste op Bruinink, D, van der Holt, B, van der Velden, VHJ, Abildgaard, N, Ahlberg, L, Andersen, N, Andreasson , B, Brandefors, L, Christiansen, HB, Faxoe, S, Fransson, C, Friestad, M, Gregersen, H, Hammerlund, Y, Hansson, M, Haukaas, E, Hector, M, Helleberg, C, Holst, M, Jönsson, AK, Karlsson, V, Klostergaard, A, Kjær, S, Lauri, B, Lenhoff, S, Lonn, I, Myhr, E, Pedersen, BH, Renna, R, Sjøgren, TV, Svirskaite, A, Szatkowski, DL, Vangsted, S, Waage, A, Schjesvold, FH, Mellqvist, U-H, Høholt, H, Madsen, LH, Christensen, HS , Brøndum, RF , Bøgsted, M & Dybkær, K 2018, 'Minimal Residual Disease (MRD) follow up of MM patients obtaining stringent complete remission (sCR) in the NMSG/EMN02 clinical trial – defining sCR numbers and prediction of disease progression by multiparametric flow cytometry (MFC).', Haematologica, bind 103, nr. S1, BA6, s. 13. <http://www.emn2018.com/doc/Abstract-book.pdf>

Minimal Residual Disease (MRD) follow up of MM patients obtaining stringent complete remission (sCR) in the NMSG/EMN02 clinical trial – defining sCR numbers and prediction of disease progression by multiparametric flow cytometry (MFC). / Johnsen, Hans Erik; Schmitz, Alexander; Bødker, Julie Støve et al.
I: Haematologica, Bind 103, Nr. S1, BA6, 2018, s. 13.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Minimal Residual Disease (MRD) follow up of MM patients obtaining stringent complete remission (sCR) in the NMSG/EMN02 clinical trial – defining sCR numbers and prediction of disease progression by multiparametric flow cytometry (MFC).

AU - Johnsen, Hans Erik

AU - Schmitz, Alexander

AU - Bødker, Julie Støve

AU - Sonneveld, P.

AU - Hofste op Bruinink, D.

AU - van der Holt, B.

AU - van der Velden, V. H. J.

AU - Abildgaard, N.

AU - Ahlberg, L.

AU - Andersen, N.

AU - Andreasson , B.

AU - Brandefors, L.

AU - Christiansen, H. B.

AU - Faxoe, S.

AU - Fransson, C.

AU - Friestad, M.

AU - Gregersen, H.

AU - Hammerlund, Y.

AU - Hansson, M.

AU - Haukaas, E.

AU - Hector, M.

AU - Helleberg, C.

AU - Holst, M.

AU - Jönsson, A.K.

AU - Karlsson, V.

AU - Klostergaard, A.

AU - Kjær, S.

AU - Lauri, B.

AU - Lenhoff, S.

AU - Lonn, I.

AU - Myhr, E.

AU - Pedersen, B. H.

AU - Renna, R.

AU - Sjøgren, T. V.

AU - Svirskaite, Asta

AU - Szatkowski, D. L.

AU - Vangsted, S.

AU - Waage, A.

AU - Schjesvold, F. H.

AU - Mellqvist, U-H

AU - Høholt, Helle

AU - Madsen, Louise Hvilshøj

AU - Christensen, Henning Sand

AU - Brøndum, Rasmus Froberg

AU - Bøgsted, Martin

AU - Dybkær, Karen

N1 - Conference code: 1

PY - 2018

Y1 - 2018

UR - http://www.emn2018.com/

M3 - Conference abstract in journal

SN - 0390-6078

VL - 103

SP - 13

JO - Haematologica

JF - Haematologica

IS - S1

M1 - BA6

T2 - 1st European Myeloma Network Meeting

Y2 - 19 April 2018 through 21 April 2018

ER -